Why Elanco Animal Health Incorporated (ELAN) stock moved
Elanco Animal Health Incorporated (ELAN) shares fell 2.7% to $25.14 as of July 21, 2026, a moderate decline from the prior close of $25.83. BestStocks flagged the session as a major change for ELAN. No single company-specific catalyst was confirmed during the move window. Below, we break down what changed for ELAN, why it matters for investors, how the stock reacted, and the catalysts on the calendar.
ELAN fell 2.7% to $25.14
ELAN fell 2.7% in its latest session, moving from $25.83 to $25.14.
What it means for Elanco Animal Health Incorporated investors
For Elanco Animal Health Incorporated investors, the recent signals are mixed, leaving the near-term picture neutral / mixed. On the constructive side: Elanco Animal Health Incorporated (ELAN) moved +1.64% from $25.54 to $25.96 on 2026-07-16, reaching a new 30-day high; Elanco Animal Health Incorporated (ELAN) moved +1.63% from $25.14 to $25.55 on 2026-07-14, reaching a new 30-day high. Weighing against that: Negative session, down 2.7%; Elanco Animal Health Incorporated (ELAN) moved −2.67% from $25.83 to $25.14 on 2026-07-20. Wall Street's consensus price target sits at $28.40, implying +13.0% upside from $25.14. BestStocks rates the overall signal quality weak (0/100). With earnings roughly 15 days out, the next report is the most likely near-term test of the move.
ELAN price reaction
ELAN last traded at $25.14, down $0.69 (-2.67%) from the previous close of $25.83. The session traded on 0.6× average volume (below avg), so participation was unremarkable. Over the past month the stock has ranged between $23.18 and $25.95, and it currently sits about 71% of the way up that band.
Bullish and bearish analyst opinions on Elanco Animal Health Incorporated (ELAN)
The consensus analyst price target on Elanco Animal Health Incorporated (ELAN) is $28.40, 13.0% above the recent $25.14. Over the past 90 days analysts logged 0 upgrades, 3 maintains, and 0 downgrades. Here is how the bullish and bearish cases on ELAN line up.
The bullish case
- Wall Street's consensus price target of $28.40 implies +13.0% upside from $25.14.
- The Street's most bullish target is $30.00 (+19.3%).
- Elanco Animal Health Incorporated (ELAN) moved +1.64% from $25.54 to $25.96 on 2026-07-16, reaching a new 30-day high.
The bearish case
- The most bearish analyst target is $23.00 (-8.5%).
- Negative session, down 2.7%.
- Elanco Animal Health Incorporated (ELAN) moved −2.67% from $25.83 to $25.14 on 2026-07-20.
Weighing both sides, BestStocks' composite read of recent signals is roughly balanced, as the bull-versus-bear meter above shows. This is an educational summary of the bull and bear case, not investment advice.
Analyst price targets and ratings are FMP consensus figures as of Jul 20, 2026; other aggregators may differ. High and low targets show the range of estimates, not forecasts.
Previous notable changes for ELAN
Frequently asked questions about ELAN
Why did Elanco Animal Health Incorporated (ELAN) stock move?
ELAN fell 2.7% to $25.14. No single company-specific catalyst was confirmed during the move window, and it looks technical.
How much did ELAN stock fall?
ELAN lost 2.67% ($0.69) versus the prior close of $25.83, last trading at $25.14 on 0.6× average volume.
When is Elanco Animal Health Incorporated's next earnings date?
ELAN's next earnings report is estimated for 2026-08-05 — about 15 days away.
What is the analyst price target for ELAN?
The consensus analyst price target for ELAN is $28.40, about 13.0% above the current $25.14. Over the past 90 days, analysts recorded 0 upgrades, 3 maintains, and 0 downgrades.
How BestStocks tracks ELAN
This page is generated automatically by BestStocks' change-detection system after its price and volume cleared ELAN-specific materiality thresholds, triggering an evidence check. It draws on 8 tracked change events for ELAN, cross-checked against the data sources listed below. Price, volume, and market-capitalization figures are the live intraday quote as of July 21, 2026 and refresh as new information is detected; for companies with multiple share classes, market-cap figures can differ by data source. Analyst price targets and ratings are FMP consensus. This is an educational summary of what changed and why — not personalized investment advice.